GPP
ABOS icon

Great Point Partners’s Acumen Pharmaceuticals ABOS Stock Holding History

Great Point Partners’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,074,101
Closed -$4.46M – 35
2023
Q3 		$4.46M Buy
1,074,101
+22,834
+2% +$141K 0.84% 35
2023
Q2 		$5.06M Hold
1,051,267
– – 1.01% 30
2023
Q1 		$4.27M Sell
1,051,267
-65,314
-6% -$341K 0.84% 30
2022
Q4 		$6.03M Sell
1,116,581
-83,419
-7% -$561K 1.25% 30
2022
Q3 		$12M Sell
1,200,000
-315,000
-21% -$1.81M 2.9% 13
2022
Q2 		$7.12M Buy
1,515,000
+586,718
+63% +$2.2M 1.83% 24
2022
Q1 		$3.63M Buy
+928,282
New +$5.05M 0.88% 25

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return